T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · Real-Time Price · USD
0.462
-0.021 (-4.39%)
At close: Nov 20, 2024, 4:00 PM
0.470
+0.008 (1.78%)
Pre-market: Nov 21, 2024, 4:00 AM EST

T2 Biosystems Revenue

T2 Biosystems had revenue of $1.99M in the quarter ending September 30, 2024, with 34.85% growth. This brings the company's revenue in the last twelve months to $7.68M, down -30.19% year-over-year. In the year 2023, T2 Biosystems had annual revenue of $7.19M, down -67.75%.

Revenue (ttm)
$7.68M
Revenue Growth
-30.19%
P/S Ratio
0.63
Revenue / Employee
$67,938
Employees
113
Market Cap
9.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.19M-15.11M-67.75%
Dec 31, 202222.31M-5.75M-20.50%
Dec 31, 202128.06M9.93M54.76%
Dec 31, 202018.13M9.80M117.52%
Dec 31, 20198.34M-2.16M-20.62%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Star Equity Holdings 47.15M
Dominari Holdings 12.59M
QT Imaging Holdings 4.04M
PAVmed 4.03M
Alterity Therapeutics 2.68M
Lyra Therapeutics 1.47M
Revenue Rankings